Anti-IFNα2 autoantibodies were largely confined to the IgG class, as few individuals had IgA or IgM reactivity to IFNα2, although 1 male COVID-19 patient (2 samples) was highly positive for anti-IFNα2 IgM (Fig 1A). This evidence concerns the gene CD79A and COVID-19.